Indirect treatment comparisons including network meta-analysis: Lenvatinib plus everolimus for the second-line treatment of advanced/metastatic renal cell carcinoma.

Indirect treatment comparisons including network meta-analysis: Lenvatinib plus everolimus for the second-line treatment of advanced/metastatic renal cell carcinoma.

<h4>Background</h4>In the absence of clinical trials providing direct efficacy results, this study compares different methods of indirect treatment comparison (ITC), and their respective impacts on efficacy estimates for lenvatinib (LEN) plus everolimus (EVE) combination therapy compared...

Full description

Saved in:
Bibliographic Details
Main Authors: Gabriel Tremblay, Heather J McElroy, Tracy Westley, Genevieve Meier, Derek Misurski, Matthew Guo
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2019-01-01
Series:PLoS ONE
Online Access:https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0212899&type=printable
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items